🔖
Cite This Article
KÜPELİ, S., ÇİMEN, D., YAĞCI, B. K. (2012). Reply: In response to “Megadose Methylprednisolone (MDMP) for Hemangiomatosis”. Turkish Journal of Hematology, Cilt: 29 - Sayı: 4, 437–437. https://ajindex.com/articles/412657
Journals / Turkish Journal of Hematology / 2012 / Cilt: 29 - Sayı: 4
Reply: In response to “Megadose Methylprednisolone (MDMP) for Hemangiomatosis”
- Pages
- 437–437
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (1)
- Küpeli S, Çimen D, Yağcı-Küpeli B. Successful treatment with propronolol in a patient with a segmental hemangioma: A case report. Turk J Hematol 2012; 29: 170-173 2. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: New clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117: 698-703. 3. Larsen, WJ. Human Embryology. New York, NY: Churchill Livingstone; 1993: 321; 360-371 4. Küpeli S. Use of propranolol for infantile hemangiomas. Pediatr Hematol Oncol 2012; 29: 293-298 5. Erbay A, Sarialioglu F, Malbora B, Yildirim SV, Varan B, Tarcan A, Gülcan H, Demir S, Derbent M, Uslu N, Abbasoğlu A. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants. Turk J Pediatr 2010; 52: 450-456 6. Özsoylu Ş. How should corticosteroid be used? Turk Med Sci 2007; 37: 123-124